Deutsche Bank Upgrades Johnson & Johnson (JNJ) to Buy; Well-Diversified and Positioned

Article Stock Quotes (1) Comments (0)

Deutsche Bank upgraded Johnson & Johnson (NYSE: JNJ) from Hold to Buy with a price target of $82.00 (from $75.00).

The firm comments, "For the past several years, JNJ has weathered through patent expirations, a general slowdown in utilization trends, and challenges with its OTC businesses. As we look ahead to 2013, we believe JNJ will see improving trends. We expect recent and new drugs to continue to drive pharma sales. A slight improvement in utilization and new products should benefit MD&D. For Consumer, J&J should continue to work through the McNeil Consent Decree and return products to market. Given these improving trends and the benefits of diversification, we believe JNJ deserves a premium to its peers."

For an analyst ratings summary and ratings history on Johnson & Johnson click here. For more ratings news on Johnson & Johnson click here.

Shares of Johnson & Johnson closed at $70.74 yesterday, with a 52 week range of $61.71-$72.74.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
• UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
• KeyBanc Boosts La-Z-Boy (LZB) Price Target

Create E-mail Alert Related Categories

Analyst PT Change, Hot Upgrades, Upgrades

Related Entities

Deutsche Bank

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?